Company: IPSC
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001104659-25-037419
Chunk: 2

Company: Century Therapeutics, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 2
---
 to serve as Class I directors, whose term will expire in 2028; 2. The ratification of the appointment of Ernst & Young LLP, or EY, as our independent registered public accounting firm for the 2025 fiscal year; and 3. Any other matters that may properly be brought before the Annual Meeting or any adjournment or postponement thereof. The foregoing items of business are more fully described in the Proxy Statement accompanying this Notice. MEETING INFORMATION

| ​ | Date:            | ​ | ​ | June 12, 2025                                                                                                                                                                                                                                                 | ​ |
|:--|:-----------------|:--|:--|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--|
| ​ | Time:            | ​ | ​ | 9:00 a.m., Eastern Time                                                                                                                                                                                                                                       | ​ |
| ​ | Website Address: | ​ | ​ | The meeting can be accessed by visiting https://web.lumiconnect.com/265375813 (password: century2025), where you will be able to listen to the meeting live, submit questions and vote online. There will be no physical location for stockholders to attend. | ​ |
| ​ | Record Date:     | ​ | ​ | You can vote if you were a stockholder of record on April 16, 2025.                                                                                                                                                                                           | ​ |

Your vote matters. Whether or not you plan to virtually attend the Annual Meeting, please ensure that your shares are represented by voting, signing, dating and returning your proxy in the enclosed envelope, which requires no postage if mailed in the United States. By Order of the Board of Directors, /s/ Douglas Carr Douglas Carr
Senior Vice President, Finance and Operations, and Secretary
April 22, 2025 IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON JUNE 12, 2025. This Proxy Statement and the proxy card are being furnished to our stockholders on or about April 22, 2025. This Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 are available to holders of our common stock at www.astproxyportal.com/ast/24419. If you would like to receive, without charge, a paper copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, including the financial statements, please send your request to Corporate Secretary, Century